OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Economic burden of multiple sclerosis in France estimated from a regional medical registry and national sick fund claims
B. Detournay, Marc Debouverie, Pereira Ouarda, et al.
Multiple Sclerosis and Related Disorders (2019) Vol. 36, pp. 101396-101396
Closed Access | Times Cited: 13
B. Detournay, Marc Debouverie, Pereira Ouarda, et al.
Multiple Sclerosis and Related Disorders (2019) Vol. 36, pp. 101396-101396
Closed Access | Times Cited: 13
Showing 13 citing articles:
Age-period-cohort analysis of the incidence of multiple sclerosis over twenty years in Lorraine, France
B. Gbaguidi, Françis Guillemin, Marc Soudant, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 25
B. Gbaguidi, Françis Guillemin, Marc Soudant, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 25
MANAGEMENT OF PATIENTS WITH ACTIVE RELAPSING-REMITTING OR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS: A FRENCH REAL-WORLD STUDY BASED ON CLAIMS DATA LINKED TO A PHASE IV STUDY
Xavier Moisset, Grégoire Mercier, Manon Belhassen, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 95, pp. 106305-106305
Closed Access
Xavier Moisset, Grégoire Mercier, Manon Belhassen, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 95, pp. 106305-106305
Closed Access
Cost of illness in multiple sclerosis by disease characteristics – A review of reviews
Dirk Schriefer, Rocco Haase, Nils-Henning Neß, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2021) Vol. 22, Iss. 2, pp. 177-195
Closed Access | Times Cited: 15
Dirk Schriefer, Rocco Haase, Nils-Henning Neß, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2021) Vol. 22, Iss. 2, pp. 177-195
Closed Access | Times Cited: 15
Real-World Treatment of Patients with Multiple Sclerosis per MS Subtype and Associated Healthcare Resource Use: An Analysis Based on 13,333 Patients in Germany
Sabrina Müller, Tobias Heidler, A. Fuchs, et al.
Neurology and Therapy (2019) Vol. 9, Iss. 1, pp. 67-83
Open Access | Times Cited: 16
Sabrina Müller, Tobias Heidler, A. Fuchs, et al.
Neurology and Therapy (2019) Vol. 9, Iss. 1, pp. 67-83
Open Access | Times Cited: 16
Secondary progressive multiple sclerosis: a systematic review of costs and health state utilities
Jeremy Chataway, Niamh Murphy, Vivek Khurana, et al.
Current Medical Research and Opinion (2021) Vol. 37, Iss. 6, pp. 995-1004
Open Access | Times Cited: 12
Jeremy Chataway, Niamh Murphy, Vivek Khurana, et al.
Current Medical Research and Opinion (2021) Vol. 37, Iss. 6, pp. 995-1004
Open Access | Times Cited: 12
Economic coordination development from the perspective of cross‐regional urban agglomerations in China
Shengxia Xu, Qiang Liu, Huihui Sun
Regional Science Policy & Practice (2022) Vol. 14, pp. 36-60
Open Access | Times Cited: 7
Shengxia Xu, Qiang Liu, Huihui Sun
Regional Science Policy & Practice (2022) Vol. 14, pp. 36-60
Open Access | Times Cited: 7
Economic Burden of Multiple Sclerosis Drugs in Iran during 2011-2019
Mina Asadollahi, Ali Darvishi, Amirreza Azimi, et al.
Iranian Journal of Public Health (2023)
Open Access | Times Cited: 2
Mina Asadollahi, Ali Darvishi, Amirreza Azimi, et al.
Iranian Journal of Public Health (2023)
Open Access | Times Cited: 2
The socioeconomic impact of multiple sclerosis in France: Results from the PETALS study
A Bouleau, C Dulong, CA Schwerer, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2022) Vol. 8, Iss. 2, pp. 205521732210932-205521732210932
Open Access | Times Cited: 3
A Bouleau, C Dulong, CA Schwerer, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2022) Vol. 8, Iss. 2, pp. 205521732210932-205521732210932
Open Access | Times Cited: 3
Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French national health insurance database
Olivier Vandhuick, M. Payet, E. Préaud, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2021) Vol. 21, Iss. 5, pp. 1135-1144
Open Access | Times Cited: 3
Olivier Vandhuick, M. Payet, E. Préaud, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2021) Vol. 21, Iss. 5, pp. 1135-1144
Open Access | Times Cited: 3
System-Level Variation in Multiple Sclerosis Care Outcomes: Initial Findings from the Multiple Sclerosis Continuous Quality Improvement Research Collaborative
Brant J. Oliver, Karen Walsh, Randall Messier, et al.
Population Health Management (2021) Vol. 25, Iss. 1, pp. 46-56
Closed Access | Times Cited: 2
Brant J. Oliver, Karen Walsh, Randall Messier, et al.
Population Health Management (2021) Vol. 25, Iss. 1, pp. 46-56
Closed Access | Times Cited: 2
Disease burden and costs associated with multiple sclerosis in China: A cross-sectional analysis of nationwide survey data
Yusheng Jia, Xuanqi Qiao, Jin Zhao, et al.
Research Square (Research Square) (2023)
Open Access
Yusheng Jia, Xuanqi Qiao, Jin Zhao, et al.
Research Square (Research Square) (2023)
Open Access
Modelling expenses for multiple sclerosis treatment
A. S. Mokrova, Susanna S. Sologova, V. Ignatyeva
(2020), Iss. 3, pp. 11-34
Closed Access
A. S. Mokrova, Susanna S. Sologova, V. Ignatyeva
(2020), Iss. 3, pp. 11-34
Closed Access
Costs of Multiple Sclerosis According to the Level of Disability: A Systematic Review Study
Selin Kalender, Vahit Yiğit
Arşiv Kaynak Tarama Dergisi (2021) Vol. 30, Iss. 2, pp. 101-118
Open Access
Selin Kalender, Vahit Yiğit
Arşiv Kaynak Tarama Dergisi (2021) Vol. 30, Iss. 2, pp. 101-118
Open Access
